⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

February 1, 1968Journal of Neurology Neurosurgery & PsychiatryOpen Access

Frequency of multiple sclerosis in three Australian cities--Perth, Newcastle, and Hobart.

M. G. McCall T. Le G. Brereton Alice Dawson Keith S. Millingen J. M. Sutherland E.D. Acheson

View Full Paper

Ask AI

Bookmark

Share

Abstract

and incidence of multiple sclerosis in three Australian cities: Perth, capital of the State of Western Australia; Newcastle, second largest city in the State of New South Wales; and Hobart, capital of the State of Tasmania. Population figures were available for each city from the census

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

McCall et al. (1968) studied this question.

synapsesocial.com/papers/6a1f77a9e47f012c48071d2c https://doi.org/10.1136/jnnp.31.1.1

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 related papers. Consider them for comparative context:

1Multiple Sclerosis in IsraelOriginal Research · 1962 · 126 citations
2DISEASE OF THE NERVOUS SYSTEM OCCURRING AMONG RESEARCH WORKERS ON SWAYBACK IN LAMBSOriginal Research · 1947 · 80 citations
3Annual incidence, prevalence, and mortality of multiple sclerosis in white South-African-born and in white immigrants to South Africa.Original Research · 1967 · 234 citations
4An Epidemiologic Approach to Multiple SclerosisOriginal Research · 1966 · 43 citations
5Functional outcome after ischaemic stroke and intracerebral haemorrhage from two national cohortsJournal of Neurology Neurosurgery & Psychiatry · Tue,

More from Journal of Neurology Neurosurgery & Psychiatry

PABPN1 pathogenic expansion in the UK Biobank: reframing genetic prevalence of oculopharyngeal muscular dystrophyWed,
Air pollution and the risk of multiple sclerosis relapses in the Paris region, the CONFISEP studyWed,
Stroke recurrence after primary intracerebral haemorrhage: a population-based study of clinical and MRI factors associated with recurrenceFri,
Comparative effectiveness of inebilizumab versus conventional immunotherapies in AQP4-IgG-positive NMOSD: a prospective cohort study with time-varying treatment effectsTue,
Age and treatment class modify inflammatory risk after disease-modifying therapy discontinuation in older people with MSMon,